Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
36.06
+0.59 (1.66%)
At close: Jun 2, 2026
Market Cap3.90B +107.1%
Revenue (ttm)197.68M +1.8%
Net Income48.60M +4.3%
EPS0.54 +17.8%
Shares Out 108.22M
PE Ratio67.34
Forward PEn/a
Dividend0.38 (1.07%)
Ex-Dividend DateMay 29, 2026
Volume1,387,724
Open35.42
Previous Close35.47
Day's Range34.51 - 36.52
52-Week Range18.20 - 43.00
Beta0.54
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 330
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.79 million, an increase of 16.93%.

Financial Statements